Physician profile
Steven Kahn
NPI 1932218500
$196,762.53
in general payments reported to CMS, 2019-2025
11 companies · $26K in 2025
The $26K reported for 2025 was more than what 98% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $9,116 · 2021: $13K · 2022: $15K · 2023: $44K · 2024: $69K · 2025: $26K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $56K · Consulting Fee: $49K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $16K · Travel and Lodging: $13K · Food and Beverage: $5,004.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $55,975.00 |
| Consulting Fee | $49,031.59 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $16,300.00 |
| Travel and Lodging | $13,246.47 |
| Food and Beverage | $5,003.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avita Medical Americas, LLC | $79,216.55 | 2019-2025 | Recell, Cohealyx, Permeaderm |
| Vericel Corporation | $74,430.36 | 2021-2025 | Nexobrid, Epicel (Cultured Epidermal Autografts) |
| Medline Industries Lp | $23,152.32 | 2019-2022 | |
| Integra Lifesciences Corporation | $11,132.12 | 2019-2025 | Integra, Omnigraft, Primatrix |
| Baxter Healthcare | $3,552.14 | 2023-2025 | Artiss |
| Mallinckrodt Hospital Products INC. | $2,920.00 | 2024 | Stratagraft |
| Lumenis Be INC | $2,000.00 | 2022 | |
| Access Pro Medical, LLC | $180.27 | 2023 | Matriderm |
| Mallinckrodt Enterprises LLC | $124.09 | 2019 | |
| Ovik Health, LLC | $33.04 | 2019 | |
| Trevena, INC. | $21.64 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Kahn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.